Balance Sheet Data

Bio-Rad Laboratories, Inc. (BIO)

$352.527

-0.65 (-0.18%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 850.361,120.21996.68875.481,796.231,292.941,363.261,437.391,515.561,597.98
Total Cash (%)
Account Receivables 393.15392.67419.42423.54494.65489.13515.73543.78573.35604.53
Account Receivables (%)
Inventories 584.33554.01622.25572.24719.32704.24742.53782.91825.49870.38
Inventories (%)
Accounts Payable 264.47287.10362.33418.93329.83380400.67422.45445.43469.65
Accounts Payable (%)
Capital Expenditure -129.83-98.53-98.92-120.80-114.16-130.15-137.23-144.69-152.56-160.85
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.